Luca Tudor Giurgea, M.D.

Clinical Research Section

NIH Main Campus, Bethesda, MD

Luca Tudor Giurgea, M.D.

Assistant Research Physician

Contact: For contact information, search the NIH Enterprise Directory.

Specialty(s): Infectious Disease, Internal Medicine
Provides direct clinical care to patients at NIH Clinical Center

Luca Tudor Giurgea, M.D.
  • Influenza
  • COVID-19
  • Vaccine development

Program Description

Dr. Giurgea’s research has focused on improving our understanding of the multifaceted immune response against respiratory viruses, including refining our comprehension of correlates of protection to improve predictive modeling of clinical outcomes. This knowledge is then applied to guide development of more durable and broadly protective next-generation vaccination strategies, with the ultimate goal of achieving universal vaccines. Dr. Giurgea has a particular interest in mucosal immunity and using multi-targeted approaches to counteract the immune escape that inevitably arises in rapidly mutating RNA viruses.



M.D., 2014, SUNY Upstate Medical University, Syracuse, NY

Dr. Giurgea earned his medical degree from the State University of New York (SUNY) Upstate Medical University in 2014 before going on to train in internal medicine at Dartmouth-Hitchcock Medical Center. He came to NIH in 2017 for a clinical fellowship in infectious diseases, where he performed bench research and ran clinical trials, including Phase 1 vaccine trials and influenza challenge trials. He joined the Laboratory of Immunoregulation in 2022 as a staff clinician, where he continues his research on respiratory viruses. He is board certified in internal medicine and infectious diseases and enjoys participating in fellow education by providing lectures and attending the infectious disease consult service.  

Selected Publications

Visit PubMed for a complete publication listing

Content last reviewed on